Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
27.75
-0.03 (-0.11%)
Official Closing Price
Updated: 4:00 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
31
32
Next >
Pfizer Announces Post-Tornado Relief Plans for Rocky Mount Community and Manufacturing Facility
July 21, 2023
From
Pfizer Inc.
Via
Business Wire
3 Undervalued Large-Cap Stocks That Won't Be for Long
July 20, 2023
Buying undervalued stocks that have unrealized catalysts will rarely disappoint investors who have the discipline to hold them over time.
Via
MarketBeat
Exposures
COVID-19
Pfizer Announces New England Journal of Medicine Publication on Group B Streptococcus (GBS) Maternal Vaccine Candidate
July 19, 2023
From
Pfizer Inc.
Via
Business Wire
Pfizer Inc. (NYSE: PFE) is One of Monday Morning’s Most Active Stocks
June 26, 2023
Via
Investor Brand Network
Exposures
COVID-19
MarketBeat Week in Review – 7/10 - 7/14
July 15, 2023
As inflation moderates, Investors are optimistic for the second quarter earnings season and that optimism is evident in some of the top stories from this week
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
3 Biotech Stocks to Buy for Long-Term Gains
July 13, 2023
The biotech sector is one of the most volatile sectors, but here are three biotech stocks that offer opportunities for patient biotech stock investors.
Via
MarketBeat
Topics
ETFs
Economy
Exposures
Interest Rates
Pfizer Just Invested $25 million In This Biotech
July 07, 2023
Pfizer's investment propels Caribou Biosciences' stock and fuels optimism for its lead candidates: CB-010 and CB-011, both currently in phase 1 trials.
Via
MarketBeat
Pfizer (NYSE: PFE) Invests $25 Million in Caribou Biosciences (NASDAQ: CRBU)
July 06, 2023
On July 6, 2023, Caribou Biosciences, Inc., a significant player in the field of CRISPR genome-editing biopharmaceuticals, announced a $25
Via
Spotlight Growth
Carrick Therapeutics Announces Clinical Trial Collaboration with Arvinas and Pfizer to Evaluate Samuraciclib and Vepdegestrant Combination
July 06, 2023
Collaboration expands Carrick’s clinical-stage Oncology program
From
CARRICK THERAPEUTICS LIMITED
Via
GlobeNewswire
Caribou Biosciences Announces $25 Million Equity Investment from Pfizer
July 06, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Chronic Plaque Psoriasis Market and Epidemiology 2032: Treatment Therapies, FDA Approvals, Companies and Patient based Forecast by DelveInsight | Dermavant Sciences, Pfizer, Arcutis Biotherapeutics
July 05, 2023
Via
AB Newswire
Exposures
Product Safety
Hemophilia A Market expected to rise | Companies – Hoffmann-La Roche, Chugai Pharmaceutical, Shire, Pfizer, BioMarin Pharmaceutical, Sinocelltech Ltd., Bayer, Ultragenix pharmaceutical
July 03, 2023
Via
AB Newswire
Immunome (NASDAQ: IMNM) and Morphimmune Announce Merger to Develop Best-in-Class Targeted Cancer Therapies
June 29, 2023
Via
Spotlight Growth
Exposures
Product Safety
FDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency
June 28, 2023
From
Pfizer Inc.
Via
Business Wire
Pleural Effusion Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies|Companies – Lung Therapeutics, Carefusion, Pfizer, Roche
June 27, 2023
Via
AB Newswire
Activision Blizzard Shares up 1.83% Amid Regulators' Blunders
June 27, 2023
Shares of Microsoft Corp. (NASDAQ: MSFT) declined 1.92% on June 26, more than the broader market, while Activision Blizzard Inc. (NASDAQ: ATVI) rose 1.83%. The S&P 500 declined 0.41% in the session.
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
Lipodystrophy Pipeline Drugs Analysis Report, 2023: FDA Approvals, Clinical Trials, Therapies, by DelveInsight | Regeneron, Ionis, Pfizer, Amunix, Zydus Cadila, Galmed, CombiGene, Carmot Therapeutics
June 27, 2023
Via
AB Newswire
Exposures
Product Safety
FDA Accepts Pfizer’s Application for Hemophilia B Gene Therapy Fidanacogene Elaparvovec
June 27, 2023
From
Pfizer Inc.
Via
Business Wire
Non Muscle Invasive Bladder Cancer Pipeline and Clinical Trials Analysis 2023 (Updated): 25+ Companies are working to improve the Treatment of Space | Pfizer, Janssen, Protara, Merck
June 27, 2023
Via
AB Newswire
Duchenne Muscular Dystrophy Market expected to rise | Companies – Sarepta Therapeutics, PTC Therapeutics, Nippon Shinyaku, Pfizer, Santhera Pharmaceuticals/ReveraGen BioPharma, Taiho Pharmaceutical
June 27, 2023
Via
AB Newswire
Multiple myeloma Pipeline and Clinical Trials Assessment 2023: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Novartis, AbbVie, Pfizer, Alliance Foundation Trials, LLC, Celgene
June 26, 2023
Via
AB Newswire
Exposures
Product Safety
Prader-Willi Syndrome Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies | Companies – Soleno Therapeutics, Levo Therapeutics, Pfizer, Novo Nordisk
June 26, 2023
Via
AB Newswire
ImmunoGen Stock Continues to Defy Gravity on Phase 2 Trials
June 26, 2023
ImmunoGen Inc. (NASDAQ: IMGN) is a commercial-stage biotechnology company leading in antibody-drug conjugates (ADC). ADCs are like heat-seeking missiles t
Via
MarketBeat
Pfizer Provides Update on GLP-1-RA Clinical Development Program for Adults with Obesity and Type 2 Diabetes Mellitus
June 26, 2023
From
Pfizer Inc.
Via
Business Wire
Leiomyosarcoma Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies |Companies – Pfizer, PTC Therapeutics, GlaxoSmithKline, AstraZeneca, Merck
June 26, 2023
Via
AB Newswire
Neuroendocrine Tumor Pipeline Drugs 2023 (Updated), FDA Approvals, Clinical Trials, MOA, ROA | MedImmune, Genentech, Merck & Co, Pfizer, Takeda Oncology, Hutchison MediPharma, and others
June 26, 2023
Via
AB Newswire
Exposures
Product Safety
FDA Approves Pfizer’s LITFULO™ (Ritlecitinib) for Adults and Adolescents With Severe Alopecia Areata
June 23, 2023
From
Pfizer Inc.
Via
Business Wire
Pfizer Declares Third-Quarter 2023 Dividend
June 22, 2023
From
Pfizer Inc.
Via
Business Wire
Cerebral Aneurysm Treatment Market, Epidemiology, Therapies, FDA Approval, Companies and Market forecast by DelveInsight | Biogen, Pfizer, Roche, Merck, Novartis, Sanofi, Teva Pharmaceutical
June 21, 2023
Via
AB Newswire
Exposures
Product Safety
Refractory Acute Myeloid Leukemia Market to witness growth by 2032, estimates DelveInsight | Pfizer, Merck, Novartis, Astellas, Amgen, Janssen, Kartos, Cullinan Oncology, Meryx
June 21, 2023
Via
AB Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.